Business Segments · Impairment Charges
Life Sciences — Impairment Charges
This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ1 2023
Last reportedQ3 2025
How to read this metric
An increase signals potential overpayment for past acquisitions or a deterioration in the segment's long-term business outlook.
Detailed definition
Non-cash charges recognized when the carrying value of an asset, such as goodwill or long-lived assets, exceeds its fair...
Peer comparison
Peers in the life sciences sector may report similar charges during periods of industry consolidation or technological shifts.
Metric ID:
dhr_segment_life_sciences_impairment_chargesHistorical Data
7 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q3 '24 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Range$0.00 – $0.00
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Danaher's life sciences — impairment charges?
- Danaher (DHR) reported life sciences — impairment charges of $0.00 in Q3 2025.
- What does life sciences — impairment charges mean?
- A write-down of asset values due to a decline in their estimated worth.